AU7043894A - Composition and method for (in vivo) imaging of amyloid deposits - Google Patents

Composition and method for (in vivo) imaging of amyloid deposits

Info

Publication number
AU7043894A
AU7043894A AU70438/94A AU7043894A AU7043894A AU 7043894 A AU7043894 A AU 7043894A AU 70438/94 A AU70438/94 A AU 70438/94A AU 7043894 A AU7043894 A AU 7043894A AU 7043894 A AU7043894 A AU 7043894A
Authority
AU
Australia
Prior art keywords
vivo
imaging
composition
amyloid deposits
amyloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70438/94A
Inventor
Ronald E Majocha
Charles A. Marotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miriam Hospital
Original Assignee
Miriam Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miriam Hospital filed Critical Miriam Hospital
Publication of AU7043894A publication Critical patent/AU7043894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU70438/94A 1993-05-28 1994-05-27 Composition and method for (in vivo) imaging of amyloid deposits Abandoned AU7043894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6901093A 1993-05-28 1993-05-28
US069010 1993-05-28
PCT/US1994/005809 WO1994028412A1 (en) 1993-05-28 1994-05-27 Composition and method for in vivo imaging of amyloid deposits

Publications (1)

Publication Number Publication Date
AU7043894A true AU7043894A (en) 1994-12-20

Family

ID=22086122

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70438/94A Abandoned AU7043894A (en) 1993-05-28 1994-05-27 Composition and method for (in vivo) imaging of amyloid deposits

Country Status (2)

Country Link
AU (1) AU7043894A (en)
WO (1) WO1994028412A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817626A (en) * 1995-03-14 1998-10-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation
CA2214247C (en) 1995-03-14 2004-02-10 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
US5854215A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals Incorporated Modulators of β-amyloid peptide aggregation
US6303567B1 (en) 1995-03-14 2001-10-16 Praecis Pharmaceuticals, Inc . Modulators of β-amyloid peptide aggregation comprising D-amino acids
US6277826B1 (en) 1996-08-27 2001-08-21 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
WO1997026919A2 (en) * 1996-01-24 1997-07-31 Warner-Lambert Company Method of imaging amyloid deposits
US6600017B1 (en) 1997-08-14 2003-07-29 The Regents Of The University Of California Fluorescent amyloid Aβ peptides and uses thereof
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US6787523B1 (en) 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
US6761888B1 (en) 2000-05-26 2004-07-13 Neuralab Limited Passive immunization treatment of Alzheimer's disease
US6743427B1 (en) 1997-12-02 2004-06-01 Neuralab Limited Prevention and treatment of amyloidogenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US6750324B1 (en) 1997-12-02 2004-06-15 Neuralab Limited Humanized and chimeric N-terminal amyloid beta-antibodies
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US6710226B1 (en) 1997-12-02 2004-03-23 Neuralab Limited Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
US20030147882A1 (en) 1998-05-21 2003-08-07 Alan Solomon Methods for amyloid removal using anti-amyloid antibodies
DE19856261C1 (en) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors
WO2000052048A1 (en) 1999-03-04 2000-09-08 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation comprising d-amino acids
US6787637B1 (en) 1999-05-28 2004-09-07 Neuralab Limited N-Terminal amyloid-β antibodies
UA81216C2 (en) 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
EP1187920A2 (en) 1999-06-09 2002-03-20 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
FR2796952B1 (en) 1999-07-30 2003-08-15 Centre Nat Rech Scient NEW APPLICATIONS OF PEPTIDES FROM THE CYTOPLASMIC DOMAIN OF THE AMYLOID PROTEIN PRECURSOR
US6589504B1 (en) 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions
US7700751B2 (en) 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
PE20050627A1 (en) 2003-05-30 2005-08-10 Wyeth Corp HUMANIZED ANTIBODIES THAT RECOGNIZE THE BETA AMYLOID PEPTIDE
PE20061329A1 (en) 2004-12-15 2006-12-08 Neuralab Ltd HUMANIZED AB ANTIBODIES TO IMPROVE COGNITION
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP2007300856A (en) * 2006-05-11 2007-11-22 Hiroshi Mori Amyloid protein imitation
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
PL2182983T3 (en) 2007-07-27 2014-10-31 Janssen Alzheimer Immunotherap Treatment of amyloidogenic diseases with humanised anti-abeta antibodies
JO3076B1 (en) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap Immunotherapy regimes dependent on apoe status
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US9102752B2 (en) 2013-03-15 2015-08-11 United Biomedical, Inc. Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434050A (en) * 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease

Also Published As

Publication number Publication date
WO1994028412A1 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
AU7043894A (en) Composition and method for (in vivo) imaging of amyloid deposits
AU1529297A (en) Method of imaging amyloid deposits
AU5921196A (en) Composition and method for tumor imaging
AU2671797A (en) Image composition method and apparatus
AU1697897A (en) Method and apparatus for the reduction of blocking effects in images
AU5822299A (en) Method and apparatus for the reduction of artifact in decompressed images using morphological post-filtering
AU7944394A (en) Improved imaging method and apparatus
AU6271994A (en) Method and apparatus for imaging
AU4846293A (en) Method and apparatus for elastographic measurement and imaging
AUPM704294A0 (en) Method and apparatus for the creation of images
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
EP0727225A3 (en) Compositions and methods for directed ultrasound imaging
GB9319619D0 (en) Imaging apparatus and method
EP0850240A4 (en) Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
IL109281A0 (en) Method for using xenon and/or krypton as a contrast enhancement agent in magnetic resonance imaging
AU5748796A (en) Methods and apparatus for image reconstruction
AU8011694A (en) Casket and method of making same
AU5988496A (en) Image enhancement method and apparatus
EP0712240A4 (en) Imaging method and its apparatus
AU4608296A (en) Methods and compositions for treatment of solid tumors in vivo
PL305607A1 (en) Plunger-type buffer for rail-vehicles and method of making same
GB9324345D0 (en) Method of and apparatus for casting
GB9310770D0 (en) Method of reducing contamination and composition for use in the method
AU7366591A (en) Method and composition for water treatment
IL108971A0 (en) Method and apparatus for high-sensitivity spect imaging of small-body organs